Please login to the form below

Not currently logged in
Email:
Password:

Apogee files two US patent applications for intradermal delivery system

Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology 

US-headquartered biotech Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology.  

The new patent applications describe advanced macromolecular formulations and coating methodologies.

Dr Alexander K Andrianov, Apogee's vice-president of R&D, said, "These filings are an important achievement of the company's ongoing research and development programme and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control."

23rd July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics